Strides Pharma Science Reports 127% Jump in Q3 Consolidated Net Profit to ₹2 Billion
Published on: Jan. 30, 2026, 12:59 p.m. | Source: scanx.trade
Strides Pharma Science achieved outstanding financial performance in Q3 with consolidated net profit reaching ₹2 billion, representing a remarkable 127% increase from ₹880 million in the same quarter last year. This substantial profit growth demonstrates the pharmaceutical company's enhanced operational efficiency, successful business execution, and strengthened market position.
